Larotaxel dihydrate has antineoplastic activity. References: Sternberg CN, Skoneczna IA, Castellano D, Theodore C, Blais N, Voog E, Bellmunt J, Peters F, Le-Guennec S, Cerbone L, Risse ML, Machiels JP. Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB). Oncology. 2013;85(4):208-15. doi: 10.1159/000354085. Epub 2013 Sep 24. PubMed PMID: 24080920.

纯度：≥98%

CAS：192573-38-9